Epirubicin Hydrochloride (10 mg)

admin — Wed, 18 Feb 2026 10:55:04 +0000

Overview: Thiotepa 15 mg Injection is a prescription anticancer medicine containing Thiotepa (15 mg) used in the treatment of various malignancies including breast cancer, ovarian cancer and bladder cancer by inhibiting DNA replication in cancer cells. Key Benefits: – Effective in select solid tumors and lymphomas – Interferes with DNA synthesis in cancer cells – Administered by trained healthcare professionals in oncology settings Composition: Thiotepa (15 mg) How It Works: Thiotepa is an alkylating agent that cross-links DNA strands, preventing cell division and leading to cancer cell death, particularly in rapidly dividing tumor cells. Usage Instructions: – Administer only by qualified healthcare professionals – Dosage and schedules vary by cancer type and patient condition – Not for self-administration Side Effects: – Bone marrow suppression leading to low blood counts – Nausea, vomiting, diarrhea – Mouth sores, fatigue Precautions: – Regular blood count and organ function monitoring is required – Increased infection and bleeding risk due to immune suppression – Avoid use during pregnancy and breastfeeding unless clearly advised Storage Instructions: – Store below 25°C, protect from light, do not freeze Manufacturer: Generic Pharmaceuticals Disclaimer: To be sold by retail on the prescription of a registered medical practitioner only.

Thiotepa 15mg – Globalstar International

Epirubicin Hydrochloride (10 mg)